Zurcher Kantonalbank (Zurich Cantonalbank) Zymeworks Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$4.82 - $7.7 $19,747 - $31,546
-4,097 Closed
0 $0
Q1 2021

May 03, 2021
SELL
$29.83 - $56.81 $31,739 - $60,445
-1,064 Reduced 20.62%
4,097 $129,000
Q4 2020

Jan 28, 2021
BUY
$39.12 - $54.99 $30,748 - $43,222
786 Added 17.97%
5,161 $244,000
Q3 2020

Nov 06, 2020
BUY
$29.21 - $46.58 $92,537 - $147,565
3,168 Added 262.47%
4,375 $204,000
Q2 2020

Jul 28, 2020
BUY
$33.67 - $40.0 $40,639 - $48,280
1,207 New
1,207 $44,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $872M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email